Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI

Melflufen and dexamethasone versus pomalidomide and dexamethasone in relapsed refractory multiple myeloma

Blood tumour mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer

Avelumab plus platinum-based chemotherapy may show some efficacy in patients with extensive-stage small cell lung cancer

Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer

Comment: EBCC 2024 highlights

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multiple myeloma

Do patients and doctors treatment aspirations align? KCCure survey – part A

Blood test may identify patients with non-small cell lung cancer subtype who can benefit from combination therapy

Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype

EAU 2024: Bladder cancer latest